Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity

Diabetes, Metabolic Syndrome and Obesity

Volumn 4, Issue , 2011, Pages 99-105

  Kreutz, Rolf P ^a,b   Alloosh, Mouhamad ^b   Mansour, Khaled ^a   Neeb, Zachary ^b   Kreutz, Yvonne ^b   Flockhart, David A ^b   Sturek, Michael ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery disease; Glucose intolerance; Insulin resistance; Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CHOLESTEROL; COLLAGEN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; THROMBIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; CARBOHYDRATE DIET; CONTROLLED STUDY; CORONARY ARTERY; HYPERTENSION; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; INTRAVENOUS GLUCOSE TOLERANCE TEST; METABOLIC SYNDROME X; MINIPIG; MORBID OBESITY; NONHUMAN; PHENOTYPE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 79953114829     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: 10.2147/DMSO.S17105     Document Type: Article

References (37)

1. Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost. 2008;99(6):995-1000.
2. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28(7):1769-1778.
3. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004;27(11):2676-2681.
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359.
5. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med. 2006;6(5):501-514.
6. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888-1904.
7. Basili S, Pacini G, Guagnano MT, et al. Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol. 2006;48(12):2531-2538.
8. Arteaga RB, Chirinos JA, Soriano AO, et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol. 2006;98(1):70-74.
9. Schneider DJ, Hardison RM, Lopes N, Sobel BE, Brooks MM; Pro-Thrombosis Ancillary Study Group. Association between increased platelet P-selectin expression and obesity in patients with type 2 diabetes: a BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy. Diabetes Care. 2009;32(5):944-949.
10. Sturek M, Alloosh M, Wenzel J, et al. Ossabaw Island miniature swine: cardiometabolic syndrome assessment. In: Swindle MM, editor. Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques. Boca Raton, FL: CRC Press; 2007:397-402.
11. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med. 2006;56(1):35-45.
12. Lloyd PG, Sheehy AF, Edwards JM, Mokelke EA, Sturek M. Leukemia inhibitory factor is upregulated in coronary arteries of Ossabaw miniature swine after stent placement. Coron Artery Dis. 2008;19(4):217-226.
13. Edwards JM, Alloosh M, Long X, et al. Adenosine A1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine. Coron Artery Dis. 2008;19(1):27-31.
14. Bratz IN, Dick GM, Tune JD, et al. Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2008;294(6):H2489-H2496.
15. 2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res. 2010;85(3):631-640.
16. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH. Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med. 2009; 234(6):683-692.
17. Lee L, Alloosh M, Saxena R, et al. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology. 2009;50(1):56-67.
18. Borbouse L, Dick GM, Asano S, et al. Impaired function of coronary BKCa channels in metabolic syndrome. Am J Physiol Heart Circ Physiol. 2009;297(5):H1629-H1637.
19. Bell LN, Lee L, Saxena R, et al. Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G746-G754.
20. Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med. 2010;60(4):300-315.
21. National Research Council. Guide for the Care and Use of Laboratory Animals. Washington, DC: The National Academies Press; 1996.
22. Beaver BV, Reed W, Leary S, et al. 2000 Report of the AVMA panel on euthanasia. J Am Vet Med Assoc. 2001;218(5):669-696.
23. Kreutz RP, Tantry US, Bliden KP, Gurbel PA. Inflammatory changes during the 'common cold' are associated with platelet activation and increased reactivity of platelets to agonists. Blood Coagul Fibrinolysis. 2007;18(8):713-718.
24. Kinlough-Rathbone RL, Rand ML, Packham MA. Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood. 1993;82(1):103-106.
25. Franchini M, Targher G, Montagnana M, Lippi G. The metabolic syndrome and the risk of arterial and venous thrombosis. Thromb Res. 2008;122(6):727-735.
26. Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS. Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2009;103(10):1339-1343.
27. Vaduganathan M, Alviar CL, Arikan ME, et al. Platelet reactivity and response to aspirin in subjects with the metabolic syndrome. Am Heart J. 2008;156(5):1002.e1-1002.e7.
28. Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196(7):887-896.
29. Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2005;25(7):1321-1324.
30. Holmes DR Jr, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol. 2010;56(17):1357-1365.
31. Kato H, Kashiwagi H, Shiraga M, et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol. 2006;26(1):224-230.
32. Konstantinides S, Schäfer K, Koschnick S, Loskutoff DJ. Leptindependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest. 2001;108(10):1533-1540.
33. Russo I, Traversa M, Bonomo K, et al. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Obesity. 2010;18(4):788-797.
34. Ferreira IA, Mocking AI, Feijge MA, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2006;26(2):417-422.
35. Otis CR, Wamhoff BR, Sturek M. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med. 2003;53(1):53-64.
36. Christoffersen BO, Grand N, Golozoubova V, Svendsen O, Raun K. Gender-associated differences in metabolic syndrome-related parameters in Göttingen minipigs. Comp Med. 2007;57(5):493-504.
37. Shukla SD, Kansra SV, Reddy MA, Shukla SM, Klachko DM, Sturek M. Platelets from diabetic pigs exhibit hypersensitivity to thrombin. Comp Med. 2008;58(5):481-484.